Biocon Limited has informed the Exchange regarding a press release dated December 23, 2021, titled "Clinical Study for Itolizumab in Lupus Nephritis Initiated in India, Post DCGIApproval".
Press Release Dec 23 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Biocon
- Press Release Dec 07 2021
- Press Release Dec 01 2021
- Press Release Nov 19 2021
- Press Release Nov 16 2021
- Press Release Nov 15 2021
Later from Biocon
- Press Release Dec 30 2021
- Press Release Jan 20 2022
- Press Release Mar 23 2022
- Press Release Mar 29 2022
- Press Release Apr 01 2022
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon